Journal
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Volume 12, Issue 1, Pages 13-19Publisher
ELSEVIER
DOI: 10.1016/j.nano.2015.09.007
Keywords
Nanotechnology; Nanomedicine; National nanotechnology initiative
Funding
- China MOST [2015CB931804]
- NSFC [81571802, J1103303, 81273548]
- US National Institutes of Health (NIAID/NIH) [R01 AI117776, R37 AI051214]
- US National Institutes of Health (NCI/NIH) [R01 CA155061]
- US National Institutes of Health (NIAMS/NIH) [U54 AR055073]
- Science and Technology Development Foundation of Fuzhou University [2013-XQ-8, 2014-XY-7]
Ask authors/readers for more resources
USA and China are two leading countries engaged in nanotechnology research and development. They compete with each other for fruits in this innovative area in a parallel and compatible manner. Understanding the status and developmental prospects of nanotechnology in USA and China is important for policy-makers to decide nanotechnology priorities and funding, and to explore new ways for global cooperation on key issues. We here present the nanoscience and nanomedicine research and the related productivity measured by publications, and patent applications, governmental funding, policies and regulations, institutional translational research, industrial and enterprise growth in nanotechnology-related fields across China and USA. The comparison reveals some marked asymmetries of nanotechnology development in China and USA, which may be helpful for future directions to strengthen nanotechnology collaboration for both countries, and for the world as a whole. (C) 2015 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available